tofogliflozin
Tofogliflozin, a novel and selective SGLT2 inhibitor improves glycemic control and lowers body weight in patients with type 2 diabetes mellitus inadequately. Reference standards of Tofogliflozin API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => Tofogliflozin-d5
[catalogue_number] => PA STI 083570
[category_ids] => ,80,71,81,78,70,82,98,
[chemical_name] =>
[weight] => 391.47
[form] => C22H21D5O6
[cas] => NA
[pslug] => tofogliflozin-d5-pasti083570
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Catalogue No.:PA STI 083570
Molecular Formula : C22H21D5O6
Molecular Weight : 391.47